WO1992004014A3 - Regulation de la proliferation de cellules neoplasiques par l'intermediaire d'un nouveau recepteur 5ht1a - Google Patents
Regulation de la proliferation de cellules neoplasiques par l'intermediaire d'un nouveau recepteur 5ht1a Download PDFInfo
- Publication number
- WO1992004014A3 WO1992004014A3 PCT/US1991/006175 US9106175W WO9204014A3 WO 1992004014 A3 WO1992004014 A3 WO 1992004014A3 US 9106175 W US9106175 W US 9106175W WO 9204014 A3 WO9204014 A3 WO 9204014A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cell proliferation
- regulation
- novel
- neoplastic cell
- 5ht1a receptor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/286—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against neuromediator receptors, e.g. serotonin receptor, dopamine receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57871090A | 1990-09-04 | 1990-09-04 | |
US578,710 | 1990-09-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1992004014A2 WO1992004014A2 (fr) | 1992-03-19 |
WO1992004014A3 true WO1992004014A3 (fr) | 1992-05-14 |
Family
ID=24313971
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1991/006176 WO1992004015A2 (fr) | 1990-09-04 | 1991-09-04 | REGULATION DE LA PROLIFERATION DE LYMPHOCYTES T VIA UN NOUVEAU RECEPTEUR, LE 5HT1a |
PCT/US1991/006175 WO1992004014A2 (fr) | 1990-09-04 | 1991-09-04 | Regulation de la proliferation de cellules neoplasiques par l'intermediaire d'un nouveau recepteur 5ht1a |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1991/006176 WO1992004015A2 (fr) | 1990-09-04 | 1991-09-04 | REGULATION DE LA PROLIFERATION DE LYMPHOCYTES T VIA UN NOUVEAU RECEPTEUR, LE 5HT1a |
Country Status (5)
Country | Link |
---|---|
EP (2) | EP0547172A1 (fr) |
JP (2) | JPH06503816A (fr) |
AU (2) | AU8499891A (fr) |
CA (2) | CA2090688A1 (fr) |
WO (2) | WO1992004015A2 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5409932A (en) * | 1993-12-09 | 1995-04-25 | Bayer Ag | Piperazine-substituted pyrroloanthracenes |
US5461054A (en) * | 1993-12-09 | 1995-10-24 | Bayer Aktiengesellschaft | Anthracene-spiro-pyrrolindines |
US5411960A (en) * | 1993-12-09 | 1995-05-02 | Bayer Aktiengesellschaft | Substituted pyrroloanthracenes and -diones |
WO1996001106A1 (fr) * | 1994-07-06 | 1996-01-18 | Bo Arne Hofmann | Emploi d'agents pharmaceutiques pour attenuer ou traiter la dysfonction immunitaire liee a l'infection par le vih ou des virus associes |
AU2880595A (en) * | 1994-07-06 | 1996-01-25 | Bo Arne Hofmann | Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses |
EP0813878B1 (fr) * | 1996-06-17 | 2002-02-06 | Mitsubishi Chemical Corporation | Agent pour accélérer la lacrimation contenant un ligand de la sérotonine, particuliérement un composé aminoalkoxybibenzyle |
US6979447B2 (en) | 2001-03-30 | 2005-12-27 | Philadelphia Health And Education Corporation | Immunomodulation and effect on cell processes relating to serotonin family receptors |
CA2681267C (fr) | 2007-04-13 | 2013-11-19 | Southern Research Institute | Agents anti-angiogeniques et procedes d'utilisation |
CN113599370B (zh) * | 2021-08-03 | 2023-12-08 | 复旦大学附属肿瘤医院 | 8-oh-dpat及其衍生物在制备抗肿瘤药物中的应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991002527A1 (fr) * | 1989-08-21 | 1991-03-07 | Beth Israel Hospital Association | Procede et composition de traitement d'hypersensibilite cutanee, oculaire et des muqueuses, d'etats inflammatoires et hyperproliferatifs en utilisant des preparations topiques d'antagonistes de serotonine |
-
1991
- 1991-09-04 CA CA002090688A patent/CA2090688A1/fr not_active Abandoned
- 1991-09-04 WO PCT/US1991/006176 patent/WO1992004015A2/fr not_active Application Discontinuation
- 1991-09-04 AU AU84998/91A patent/AU8499891A/en not_active Abandoned
- 1991-09-04 WO PCT/US1991/006175 patent/WO1992004014A2/fr not_active Application Discontinuation
- 1991-09-04 AU AU88482/91A patent/AU8848291A/en not_active Abandoned
- 1991-09-04 EP EP91918533A patent/EP0547172A1/fr not_active Withdrawn
- 1991-09-04 EP EP91915814A patent/EP0555231A1/fr not_active Withdrawn
- 1991-09-04 JP JP3517820A patent/JPH06503816A/ja active Pending
- 1991-09-04 JP JP3514697A patent/JPH06500775A/ja active Pending
- 1991-09-04 CA CA002090689A patent/CA2090689A1/fr not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991002527A1 (fr) * | 1989-08-21 | 1991-03-07 | Beth Israel Hospital Association | Procede et composition de traitement d'hypersensibilite cutanee, oculaire et des muqueuses, d'etats inflammatoires et hyperproliferatifs en utilisant des preparations topiques d'antagonistes de serotonine |
Non-Patent Citations (6)
Title |
---|
Cancer Research, vol. 48, no. 15, 1 August 1988, (Philadelphia, US), T. MANDA et al.: "Important role of serotonin in the antitumor effects of recombinant human tumor necrosis factor-alpha in mice", pages 4250-4255, see the abstract * |
European Journal of Pharmacology, vol. 170, no. 1/2, October 1989, (Amsterdam, NL), M.R. PRANZATELLI et al.: "Identification of 5-HT1A recognition sites in human ganglioneuroblastoma", pages 127-128, see the whole document * |
Nature, vol. 335, 22 September 1988, (London, GB), A. FARGIN et al.: "The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor", pages 358-360, see page 359, right-hand column, lines 1-14; figure 4; table 1 (cited in the application) * |
New England Journal of Medicine, vol. 277, no. 21, 1967, (Boston, US), K. ENGELMAN et al.: "Inhibition of serotonin synthesis by para-chlorophenylalanine in patients with the carcinoid syndrome", pages 1103-1108, see the abstract * |
Proceedings of the National Academy of Sciences of USA, vol. 81, no. 6, March 1984, (Washington, DC, US), P. DANNIES et al.: "Spiperone: Evidence for uptake into secretory granules", pages 1867-1870, see the whole document * |
The Merck Index, 11th edition (Eds. S. BUDAVARI et al.), 1989, Merck & Co., Rahway, NJ, US, see no 6097. Mianserin; no. 8707. Spiperone * |
Also Published As
Publication number | Publication date |
---|---|
CA2090688A1 (fr) | 1992-03-05 |
WO1992004015A2 (fr) | 1992-03-19 |
EP0555231A1 (fr) | 1993-08-18 |
JPH06503816A (ja) | 1994-04-28 |
EP0547172A1 (fr) | 1993-06-23 |
WO1992004015A3 (fr) | 1992-04-16 |
AU8848291A (en) | 1992-03-30 |
CA2090689A1 (fr) | 1992-03-05 |
AU8499891A (en) | 1992-03-30 |
WO1992004014A2 (fr) | 1992-03-19 |
JPH06500775A (ja) | 1994-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MD1616F2 (en) | Tricyclic compounds and method of inhibiting the tyrasin kinases receptors of the epidermal growth factor, pharmaceutical composition, methods of preventing the blastocites implantation and mammals treatment | |
ES8801789A1 (es) | Un procedimiento para la preparacion de derivados de indol | |
MY131298A (en) | 5-heteroyl indole derivatives | |
AU1710183A (en) | Pyridine-n-oxide derivatives | |
EG19322A (en) | 1-(0-cyclopropylcarbonyl phenyl sulfamoyl) 3-(4,6-dimethoxy-2-pyrimidinyl) ure and method for the preparation there of | |
AU6944091A (en) | Indole-substituted five-membered heteroaromatic compounds | |
MY118556A (en) | Catalytic composition suitable for the fischer-tropsch process | |
EP0354777A3 (fr) | Dérivés du 3-(4-pipéridine)-5-(2-sulfonylaminoéthyl)-indole | |
EP0351112A3 (fr) | Composé photochromique, procédé de préparation, son application et composition photochromique le contenant | |
PT82127A (en) | Process for the preparation of phenyl carbamates | |
GR3026506T3 (en) | Indole derivatives as serotonin antagonists | |
WO1992004014A3 (fr) | Regulation de la proliferation de cellules neoplasiques par l'intermediaire d'un nouveau recepteur 5ht1a | |
AU2999684A (en) | Substituted 2-(monoannelated (3,4-, 4,5- and 5,6-) pyridylalkylenesulfinyl)-benzimidazoles | |
ZA955686B (en) | Positive photoactive compounds based on 2,6-dinitro benzyl groups | |
BG101875A (en) | New cryptoficins and method for their preparation | |
ATE423555T1 (de) | Verwendung von beta-3-adrenergen-rezeptoren agonisten in der behandlung von dysurie | |
CA2080249A1 (fr) | Obtention de piperidines a substituant | |
NO911490L (no) | Fremgangsmaate for hydrogenperoksydbleking av papirmasse, med hoeyt utbytte. | |
MX9801133A (es) | Agente endoparasiticida a base de didepsipeptidos, nuevos didepsipeptidos y procedimiento para su produccion. | |
DE3168175D1 (en) | Isonicotinanilide derivatives, process for preparing the same and plant growth regulator containing the same | |
AU566900B2 (en) | 2,3-dihydro-3-oxo-1h-isoindole derivatives | |
AU4771099A (en) | Substituted 2,4-diamino-1,3,5-triazines, methods for the production thereof and their use as herbicides and plant growth regulators | |
AU4439389A (en) | Chemical process for the preparation of imidazoquinoxalines and intermediates for use in the process | |
IL64319A (en) | Plant growth regulating compositions containing bicyclo(2.2.1)heptane-2-oxime derivatives,certain such novel compounds and their preparation | |
AU591784B2 (en) | New process for the synthesis of N-amino-3- azabicyclo (3,3,0) octane |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 8-12,18,28,44,DESCRIPTION AND PAGES 1/23,4/23,6/23-8/23,10/23-12/23,14/23-16/23,19/23-23/23,DRAWINGS,REPLACED BY NEW PAGES BEARING THE SAME NUMBER;AFTER THE RECTIFICATION OF OBVIOUS ERRORS AS AUTHORIZED BY THE UNITED STATES PATENT AND TRADEMARKS OFFICE IN ITS CAPACITY AS INTERNATIONAL SEARCHING AUTHORITY |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1991915814 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2090688 Country of ref document: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 1991915814 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1991915814 Country of ref document: EP |